Showing studies matching your search2 results shown
Studies (2 shown)
NCT06858319PHASE3RECRUITING
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Sponsor · Novartis PharmaceuticalsCondition · Kidney Diseases, Kidney Diseases, ChronicIntervention · zigakibartUpdated May 2026
NCT05852938PHASE3ACTIVE_NOT_RECRUITING
A Study of Zigakibart in Adults With IgA Nephropathy
Sponsor · Novartis PharmaceuticalsCondition · IgA Nephropathy, Immunoglobulin A NephropathyIntervention · BION-1301, PlaceboUpdated Apr 2026
Showing top 2 results. See all 2 results on CT.gov →